D0827 | c.i. basic violet 14
| Toxicity | Dose | Time | Species | Model | Method | Action | Positive criterion | Reference |
|---|---|---|---|---|---|---|---|---|
| MEMBRANE POTENTIAL | 0.18±0.16 | human | qHTS-HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 0.87 | human | HepG2 | MMP assay | decrease | IC50 | 163 | |
| MEMBRANE POTENTIAL | 6.84±4.71 | rat | hepatocytes | MMP assay | decrease | IC50 | 163 | |
| Pictogram | Signal | Statements | Precautionary Statement Codes |
|---|---|---|---|
   |
Warning |
Aggregated GHS information provided by 141 companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. Reported as not meeting GHS hazard criteria by 5 of 141 companies. For more detailed information, please visit ECHA C&L website Of the 11 notification(s) provided by 136 of 141 companies with hazard statement code(s): H302 (33.82%): Harmful if swallowed [Warning Acute toxicity, oral] H315 (33.82%): Causes skin irritation [Warning Skin corrosion/irritation] H319 (34.56%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H351 (63.24%): Suspected of causing cancer [Warning Carcinogenicity] H411 (31.62%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P201, P202, P264, P270, P273, P280, P281, P301+P312, P302+P352, P305+P351+P338, P308+P313, P321, P330, P332+P313, P337+P313, P362, P391, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
|
|
Warning |
Aggregated GHS information provided by 40 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] H351 (100%): Suspected of causing cancer [Warning Carcinogenicity] Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. |
P201, P202, P264, P270, P281, P301+P312, P308+P313, P330, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
|
|
Warning |
H351: Suspected of causing cancer [Warning Carcinogenicity] |
P201, P202, P281, P308+P313, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
|
|
Warning |
H351: Suspected of causing cancer [Warning Carcinogenicity] |
P201, P202, P281, P308+P313, P405, and P501; (The corresponding statement to each P-code can be found at the GHS Classification page.) |
| (4-(4-Aminophenyl)(4-iminocyclohexa-2,5-dienylidene)methyl)-2-methylaniline hydrochloride | 12418 Red | 2, .alpha.(sup4)-(p-aminophenyl)-.alpha.(sup4)-(4-imino-2,5-cyclohexadien-1-ylidene)-, monohydrochloride |
| 2-Methyl-4,5-cyclohexadien-1-ylidene)methylene]dianiline hydrochloride | 4-((4-AMINO-3-ME-PH)(4-AMINO-PH)METHYLENE)-2,5-CYCLOHEXADIEN-1-IMINIUM CHLORIDE | 4-((4-Aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl)-2- methylbenzenamine monohydrochloride |
| 4-((4-Aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl)-2-methylbenzenamine HCl | 4-((4-aminophenyl)(4-iminocyclohexa-2,5-dienylidene)methyl)-2-methylaniline hydrochloride | 4-Amino-m-tolyl-bis(4-aminophenyl)methane chloride |
| 4-[(4-amino-3-methylphenyl)(4-aminophenyl)methylidene]cyclohexa-2,5-dien-1-iminium chloride | 4-[(4-aminophenyl)(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline hydrochloride | 4-[(4-aminophenyl)-(4-iminocyclohexa-2,5-dien-1-ylidene)methyl]-2-methylaniline;hydrochloride |
| 4-{(Z)-(4-aminophenyl)[(4Z)-4-iminocyclohexa-2,5-dien-1-ylidene]methyl}-2-methylaniline hydrochloride | 58969-01-0 | 632-99-5 |
| 8UUC89LHB2 | AI3-18324 | AKOS015902644 |
| Aizen magenta | Aniline red | Astra fuchsine B |
| BASIC FUCHSIN HYDROCHLORIDE | BASIC FUCHSIN, BIOLOGICAL STAIN | Basic Fuchsin (BV14) Magenta (C.I. 42510) |
| Basic Fuchsin, 70+%, pure, certified | Basic Fuchsin, 88%, pure | Basic Fuchsine (VAN) |
| Basic Violet 14 hydrochloride | Basic blue 14 | Basic fuchsine |
| Basic magenta | Basic magenta E-200 | Basic violet 14 |
| Benzenamine, 4-((4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl)-2-methyl-, hydrochloride (1:1) | Benzenamine, 4-((4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl)-2-methyl-, monohydrochloride | Benzenamine, 4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, hydrochloride (1:1) |
| Benzenamine,4-[(4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, monohydrochloride; | Benzenamine,5-cyclohexadien-1-ylidene)methyl]-2-methyl-, monohydrochloride | Benzeneamine, 4-((4-aminophenyl)(4-imino-2,5-cyclohexadien-1-ylidene)methyl)-2-methyl-, monohydrochloride |
| C-WR Violet 8 | C.I. 42510 | C.I. Basic Violet 14 |
| C.I. Basic Violet 14 monohydrochloride | C.I. Basic Violet 14, monohydrochloride | C.I. Basic Violet 14, monohydrochloride (8CI) |
| C19252 | C20H19N3.HCl | CAS-632-99-5 |
| CCRIS 366 | CHEBI:87665 | CHEMBL1979636 |
| CI 42510 | CI Basic Violet 14 | CI Basic Violet 14, monohydrochloride |
| CS-0013370 | Calcozine Magenta RIN | Calcozine Magenta RTN |
| Calcozine fuchsine HO | Calcozine magenta XX | Cerise B |
| DSSTox_CID_1246 | DSSTox_GSID_21246 | DSSTox_RID_76036 |
| DTXSID6021246 | Diabasic magenta | Diamond Fuchsin |
| Diamond fuchsine | EINECS 211-189-6 | F-7910 |
| FT-0626556 | Fuchsin | Fuchsin basic |
| Fuchsin, basic | Fuchsin, basic [USP] | Fuchsine |
| Fuchsine A | Fuchsine CS | Fuchsine Crystals |
| Fuchsine G | Fuchsine HO | Fuchsine N |
| Fuchsine RTN | Fuchsine Y | Fuchsine base (monohydrochloride) |
| Fuchsine basic monohydrochloride | HSDB 6192 | HY-B1539A |
| LS-275 | MAGENTA | MAGENTA CRYSTALS |
| MCULE-3364364619 | MFCD00012569 | Magenta DP |
| Magenta E | Magenta G | Magenta I |
| Magenta I [Magenta (containing C.I. Basic Red 9)] | Magenta Large Crystals | Magenta PN |
| Magenta Powder N | Magenta S | Magenta Super Fine |
| Magenta superfine | Magenta supertine | Magentatrade mark |
| Manufacture of magenta | Methyl fuchsin | Mitsui Magenta |
| NCGC00166015-01 | NCGC00260336-01 | NSC 10466 |
| NSC 93739 | NSC-10466 | NSC-93739 |
| NSC10466 | NSC93739 | Orient Basic Magenta |
| Q419167 | Rosaniline | Rosaniline Dyes |
| Rosaniline chloride | Rosaniline hydrochloride | Rosaniline.HCl |
| Rosanilinium chloride | Rosanilinium hydrochloride | Rose aniline |
| SCHEMBL23402 | Schiff Reagent Solution | Solvent Red 41 |
| T322 | Tox21_112288 | Tox21_202790 |
| UNII-5P5C03819W component NIKFYOSELWJIOF-SVFFXJIWSA-N | UNII-8UUC89LHB2 | Violet zasadita 14 |
| Violet zasadita 14 [Czech] | WLN: L6Y DYJ AUYR DZ&R DZ C1& DUM &GH | rosanilin |